Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy - Eckard, Allison Ross; Jiang, Ying; Debanne, Sara M.; Funderburg, Nicholas T.; McComsey, Grace A. (The Journal of infectious diseases, 2014)
Keywords: 1-Alkyl-2-acetylglycerophosphocholine Esterase - blood; Adult; Anti-Retroviral Agents - therapeutic use; Biological and medical sciences; Biomarkers; Cardiovascular diseases; Cardiovascular Diseases - blood; Cardiovascular Diseases - drug therapy; Cholesterol, LDL - blood; Cholesterols; Coagulation; Double-Blind Method; Female; Fluorobenzenes - therapeutic use; Fundamental and applied biological sciences. Psychology; HIV; HIV infections; HIV Infections - blood; HIV Infections - drug therapy; HIV/AIDS; Human immunodeficiency virus; Human viral diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Infectious diseases; Inflammation; Major and Brief Reports; Male; Medical sciences; Microbiology; Middle Aged; Nadir; Placebos; Prospective Studies; Pyrimidines - therapeutic use; Regression Analysis; Risk Factors; RNA; Rosuvastatin Calcium; Sulfonamides - therapeutic use; T lymphocytes; Treatment Outcome; Vasculitis - blood; Vasculitis - drug therapy; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; Infection; Immunopathology; Antiretroviral agent; Treatment; Viral disease; Antiviral; AIDS; Statin derivative; Inflammation; Immune deficiency; Antilipemic agent; cardiovascular disease; HIV; statin; inflammation; coagulation; lipoprotein-associated phospholipase A2